FTH1 and breast carcinoma: Recent observations in preclinical breast cancer models suggest that FTH1 is a significant tumor suppressor by inhibiting the expression of key oncogenes, such as c-MYC, and that its increased expression signifies a favorable prognosis and response to chemotherapy [24].